Therefore, based on our present results along with the clear association of FAM46A with the abnormal bone phenotypes in the FAM46AE157*Mhda mice and OI patients, it is reasonable to suggest that FAM46A is likely a critical intracellular modulator of the TGF-β superfamily. The gene discussed is TGFB1; the disease is osteogenesis imperfecta.